Evidence supporting the use of: DHA (Docosahexaenoic Acid)
For the health condition: Anxiety Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

DHA (Docosahexaenoic Acid), an omega-3 fatty acid found primarily in fish oils, has garnered some scientific interest as a potential adjunct in the management of anxiety disorders. The rationale for its use is based on the role of omega-3 fatty acids in brain function, neurotransmitter modulation, and anti-inflammatory effects. Several observational studies have suggested a correlation between low omega-3 intake and higher prevalence of mood and anxiety disorders. However, direct evidence from randomized controlled trials (RCTs) specifically examining DHA supplementation for anxiety is limited and mixed. Some small-scale studies and meta-analyses of omega-3 supplementation (often combining DHA and EPA) have shown modest reductions in anxiety symptoms, but typically the effect size is small and the quality of evidence is low to moderate. Additionally, many of these studies use mixed formulations, making it difficult to isolate the effects of DHA alone. Major clinical guidelines do not currently recommend DHA supplementation as a first-line or standalone treatment for anxiety disorders. Therefore, while there is some scientific rationale and preliminary evidence supporting the potential benefit of DHA in anxiety, the evidence base is insufficient to warrant strong clinical recommendations. More large, well-designed clinical trials are needed to conclusively determine its efficacy.

More about DHA (Docosahexaenoic Acid)
More about Anxiety Disorders

Products containing DHA (Docosahexaenoic Acid)

We currently have no products on Vitabase that contain this ingredient.